Congenital heart disease echocardiography

Jump to navigation Jump to search

Congenital heart disease Microchapters

Home

Patient Information

Overview

Anatomy

Classification

Pathophysiology

Causes

Differentiating Congenital heart disease from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Prenatal Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Prevention

Outcomes

Reproduction

Case Studies

Case #1

Congenital heart disease echocardiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Congenital heart disease echocardiography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congenital heart disease echocardiography

CDC on Congenital heart disease echocardiography

Congenital heart disease echocardiography in the news

Blogs on Congenital heart disease echocardiography

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Congenital heart disease echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Keri Shafer, M.D. [2], Atif Mohammad, M.D., Priyamvada Singh, MBBS

Overview

Echocardiography

Fetal Echocardiography (M-Mode) along with Doppler ultrasonography, have helped to diagnose the abnormalities in structure and function of fetal heart in utero. It could be done as early as 16 weeks of gestation. It has helped the physicians to make better management plans for pregnancy, delivery, post-natal period and parental counseling. M-mode Echocardiography can also pick arrhythmia in utero. The early detection of arrhythmia are of great importance, as it could be treated by maternal administration of anti-arrhythmic drugs like digoxin, procainamide, propranolol (reaches the fetus transplacentally)or could be directly injected to the umbilical veins of fetus.


It has become the standard for diagnosis of congenital heart malformations. It could diagnose malformations like coarctation of aorta, patent ductus arteriosus, hypoplastic left heart syndrome and others with great confidence.[1]

References

  1. Braunwald Zipes Libby. Heart disease: A textbook of cardiovascular medicine, 6th Edition chapter 43:W.B. Saunders ;.pp 1523

de:Herzfehler lv:Iedzimtās sirds slimības nn:Medfødd hjartefeil sr:Урођене срчане мане uk:Вроджені вади серця wa:Maladeye des bleus påpåds


Template:WikiDoc Sources